Olanzapine and Progesterone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Olanzapine (olanzapine) and Progesterone (progesterone). Common drug interactions include headache among females and transaminases increased among males.

The phase IV clinical study analyzes what interactions people have when they take Olanzapine and Progesterone. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Olanzapine?

Olanzapine has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 69,242 Olanzapine users. Check the latest studies of Olanzapine.

What is Progesterone?

Progesterone has active ingredients of progesterone. It is often used in menopause. eHealthMe is studying from 21,021 Progesterone users. Check the latest studies of Progesterone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 24, 2026

43 people who take Olanzapine and Progesterone together, and have interactions are studied.

Olanzapine and Progesterone drug interactions.

What are the common drug interactions of Olanzapine and Progesterone, by gender? *:

female:

Headache (pain in head)
Tremor (trembling or shaking movements in one or more parts of your body)
Abdominal distension
Breath odour
Chills (felling of cold)
Deja vu (the experience of thinking that a new situation had occurred before)
Delusion (a false belief or opinion)
Depressed mood
Dysarthria (speech disorder)
Ear congestion

male:

Transaminases increased
Adverse drug reaction
Personality disorder
Psychotic disorder
Suicidal ideation
Suicide attempt

What are the common drug interactions of Olanzapine and Progesterone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Feeling cold
Frequent bowel movements
Grip strength decreased
Headache (pain in head)
Hot flush (sudden feelings of heat)
Hyperacusis (disorder in loudness perception)
Hypersomnia (excessive daytime sleepiness (eds))
Intentional self-injury
Mania (a state of abnormally elevated or irritable mood)
Mydriasis (a dilation of the pupil)

20-29:

Premature delivery
Transaminases increased
Maternal exposure during pregnancy (use of substance during pregnancy)
Apnoea (suspension of external breathing)
Asthenia (weakness)
Chest pain
Dizziness
Dyspepsia (indigestion)
Gastritis (inflammation of stomach)
Headache (pain in head)

30-39:

n/a

40-49:

Febrile neutropenia (fever with reduced white blood cells)
Abortion spontaneous (naturally occurring miscarriage)
Cytogenetic abnormality

50-59:

Drug ineffective
Febrile neutropenia (fever with reduced white blood cells)
Injection site irritation
Insomnia (sleeplessness)
Abasia (inability to walk)
Abdominal pain
Accidental exposure
Adverse drug reaction
Balance disorder
Diplopia (double vision)

60+:

Central nervous system lesion (an abnormality in tissue of brain or spinal cord)
Subarachnoid haemorrhage (blood leaks into the space between two membranes that surround the brain)
Dizziness
Dysphagia (a condition in which swallowing is difficult or painful)
Eye movement disorder
Faecal incontinence (a lack of control over passing stool)
Fatigue (feeling of tiredness)
Functional gastrointestinal disorder (functional problem in separate organs of gastrointestinal system)
Gait disturbance
Heart rate increased

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 16.28%
Stress And Anxiety: 5 people, 11.63%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 11.63%
Maternal Therapy To Enhance Foetal Lung Maturity: 4 people, 9.30%
Tocolysis (inhibition of uterine contractions): 3 people, 6.98%
Sleep Disorder: 3 people, 6.98%
Mania (a state of abnormally elevated or irritable mood): 3 people, 6.98%
Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 6.98%
Depression: 3 people, 6.98%
Agitation (state of anxiety or nervous excitement): 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Olanzapine and Progesterone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously